Literature DB >> 8395866

In situ localization of PTH/PTHrP receptor mRNA in the bone of fetal and young rats.

K Lee1, J D Deeds, A T Bond, H Jüppner, A B Abou-Samra, G V Segre.   

Abstract

We characterized cells that express parathyroid hormone/parathyroid hormone related peptide (PTH/PTHrP) receptor mRNA in bones of fetal and postnatal rats by in situ hybridization. During endochondral development of fetal bones, PTH/PTHrP receptor transcripts were highly expressed both in maturing chondrocytes and in osteoblasts in the periosteum and ossification center, but not in fully hypertrophic chondrocytes. Similar to the localization in the fetal bones, PTH/PTHrP receptor mRNA expression was highly localized to maturing chondrocytes in the articular cartilage and growth plate, and to osteoblasts in the femur of young rats. In both young and fetal rats, transcripts for Type X collagen were localized to hypertrophic chondrocytes, mostly between chondrocytes and bone cells both of which express PTH/PTHrP receptor mRNA. Transcripts for PTH/PTHrP receptors and alkaline phosphatase co-localized in the bone of young rats, but they did not co-localize in fetal bones at the early stages of endochondral ossification. These results show that PTH/PTHrP receptor mRNA is expressed in a cell-type and stage-specific manner during skeletal development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395866     DOI: 10.1016/8756-3282(93)90162-4

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  20 in total

Review 1.  Bone development in the fetus and neonate: role of the calciotropic hormones.

Authors:  Christopher S Kovacs
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

2.  Expression of the parathyroid hormone receptor and correlation with other osteoblastic parameters in fetal rat osteoblasts.

Authors:  M P Bos; J M van der Meer; J H Feyen; M P Herrmann-Erlee
Journal:  Calcif Tissue Int       Date:  1996-02       Impact factor: 4.333

3.  Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.

Authors:  T Ishizuya; S Yokose; M Hori; T Noda; T Suda; S Yoshiki; A Yamaguchi
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 4.  Role of G-proteins in the differentiation of epiphyseal chondrocytes.

Authors:  Andrei S Chagin; Henry M Kronenberg
Journal:  J Mol Endocrinol       Date:  2014-06-30       Impact factor: 5.098

Review 5.  The role of biomineralization in disorders of skeletal development and tooth formation.

Authors:  Christopher S Kovacs; Catherine Chaussain; Philip Osdoby; Maria Luisa Brandi; Bart Clarke; Rajesh V Thakker
Journal:  Nat Rev Endocrinol       Date:  2021-05-04       Impact factor: 43.330

6.  Expression of parathyroid hormone-related peptide (PthrP) and its receptor (PTH1R) during the histogenesis of cartilage and bone in the chicken mandibular process.

Authors:  Qiong Zhao; Philip R Brauer; Lei Xiao; Michael H McGuire; John A Yee
Journal:  J Anat       Date:  2002-08       Impact factor: 2.610

Review 7.  Bone disease in pediatric chronic kidney disease.

Authors:  Katherine Wesseling-Perry
Journal:  Pediatr Nephrol       Date:  2012-10-14       Impact factor: 3.714

8.  Identification of SOX9 interaction sites in the genome of chondrocytes.

Authors:  Chun-do Oh; Sankar N Maity; Jing-Fang Lu; Jiexin Zhang; Shoudan Liang; Francoise Coustry; Benoit de Crombrugghe; Hideyo Yasuda
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

Review 9.  The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications.

Authors:  Katherine Wesseling-Perry; Harald Jüppner
Journal:  Bone       Date:  2012-10-16       Impact factor: 4.398

10.  TIP39/parathyroid hormone type 2 receptor signaling is a potent inhibitor of chondrocyte proliferation and differentiation.

Authors:  Dibiyendu Panda; David Goltzman; Harald Jüppner; Andrew C Karaplis
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-25       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.